Drug profile · INN
etonogestrel
IMPLANON NXT
etonogestrel (IMPLANON NXT) is a progesterone receptor agonist. Associated with Organon Pharma Pty Ltd. Route of administration: implantation. Current US regulatory status: approved.
Drug details — etonogestrel
- US status
- approved
- Class
- —
- Route
- IMPLANTATION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
etonogestrel (IMPLANON NXT) is a progesterone receptor agonist. Associated with Organon Pharma Pty Ltd. Route of administration: implantation. Current US regulatory status: approved.
Key facts
Mechanism of action
Progesterone receptor agonist
Primary target: Progesterone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is etonogestrel?
etonogestrel (IMPLANON NXT) is a progesterone receptor agonist. Associated with Organon Pharma Pty Ltd. Route of administration: implantation. Current US regulatory status: approved.
What is the brand name for etonogestrel?
IMPLANON NXT is a marketed brand name for etonogestrel. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of etonogestrel?
etonogestrel has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.